Investigation of Peptidoglycan-Associated Lipoprotein of Acinetobacter baumannii and Its Interaction with Fibronectin To Find Its Therapeutic Potential

Acinetobacter baumannii causes hospital-acquired infections and is responsible for high mortality and morbidity. The interaction of this bacterium with the host is critical in bacterial pathogenesis and infection. ABSTRACT Acinetobacter baumannii causes hospital-acquired infections and is responsible for high mortality and morbidity. The interaction of this bacterium with the host is critical in bacterial pathogenesis and infection. Here, we report the interaction of peptidoglycan-associated lipoprotein (PAL) of A. baumannii with host fibronectin (FN) to find its therapeutic potential. The proteome of A. baumannii was explored in the host-pathogen interaction database to filter out the PAL of the bacterial outer membrane that interacts with the host’s FN protein. This interaction was confirmed experimentally using purified recombinant PAL and pure FN protein. To investigate the pleiotropic role of PAL protein, different biochemical assays using wild-type PAL and PAL mutants were performed. The result showed that PAL mediates bacterial pathogenesis, adherence, and invasion in host pulmonary epithelial cells and has a role in the biofilm formation, bacterial motility, and membrane integrity of bacteria. All of the results suggest that PAL’s interaction with FN plays a vital role in host-cell interaction. In addition, the PAL protein also interacts with Toll-like receptor 2 and MARCO receptor, which suggests the role of PAL protein in innate immune responses. We have also investigated the therapeutic potential of this protein for vaccine and therapeutic design. Using reverse vaccinology, PAL’s potential epitopes were filtered out that exhibit binding potential with host major histocompatibility complex class I (MHC-I), MHC-II, and B cells, suggesting that PAL protein is a potential vaccine target. The immune simulation showed that PAL protein could elevate innate and adaptive immune response with the generation of memory cells and would have subsequent potential to eliminate bacterial infection. Therefore, the present study highlights the interaction ability of a novel host-pathogen interacting partner (PAL-FN) and uncovers its therapeutic potential to combat infection caused by A. baumannii.

[1]  Vishvanath Tiwari,et al.  Potentiate the activity of current antibiotics by naringin dihydrochalcone targeting the AdeABC efflux pump of multidrug-resistant Acinetobacter baumannii. , 2022, International journal of biological macromolecules.

[2]  S. McClean,et al.  Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It , 2021, Vaccines.

[3]  C. Cluzel,et al.  Incidence of an intracellular multiplication niche amongst Acinetobacter baumannii clinical isolates , 2021, bioRxiv.

[4]  Vandana Solanki,et al.  Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2 , 2021, PeerJ.

[5]  I. Kyriakidis,et al.  Acinetobacter baumannii Antibiotic Resistance Mechanisms , 2021, Pathogens.

[6]  Quentin J. Leclerc,et al.  Antimicrobial resistance and COVID-19: Intersections and implications , 2021, eLife.

[7]  Vandana Solanki,et al.  Subtractive Proteomics and Reverse Vaccinology Strategies for Designing a Multiepitope Vaccine Targeting Membrane Proteins of Klebsiella pneumoniae , 2021, International Journal of Peptide Research and Therapeutics.

[8]  Vishvanath Tiwari Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus , 2021, International Journal of Biological Macromolecules.

[9]  G. Wilharm,et al.  Novel Genes Required for Surface-Associated Motility in Acinetobacter baumannii , 2020, Current Microbiology.

[10]  Vandana Solanki,et al.  Subtractive proteomic analysis of antigenic extracellular proteins and design a multi‐epitope vaccine against Staphylococcus aureus , 2020, Microbiology and immunology.

[11]  Patrick S. Gellings,et al.  Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine , 2020, Pathogens.

[12]  W. Lima,et al.  Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution? , 2020, Medical Hypotheses.

[13]  C. Kleanthous,et al.  The multifarious roles of Tol-Pal in Gram-negative bacteria , 2020, FEMS microbiology reviews.

[14]  B. Zhu,et al.  Co-infection with respiratory pathogens among COVID-2019 cases , 2020, Virus Research.

[15]  Vishvanath Tiwari,et al.  Rational targeting of Wzb phosphatase and Wzc kinase interaction inhibits extracellular polysaccharides synthesis and biofilm formation in Acinetobacter baumannii. , 2020, Carbohydrate research.

[16]  C. Ayoub Moubareck,et al.  Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen , 2020, Antibiotics.

[17]  Seungwoo Hwang,et al.  IL-10 Protects Mice From the Lung Infection of Acinetobacter baumannii and Contributes to Bacterial Clearance by Regulating STAT3-Mediated MARCO Expression in Macrophages , 2020, Frontiers in Immunology.

[18]  B. He,et al.  The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of Burkholderia mallei and provides protection against lethal aerosol challenge , 2020, Virulence.

[19]  B. Dam,et al.  Adaptation of ethidium bromide fluorescence assay to monitor activity of efflux pumps in bacterial pure cultures or mixed population from environmental samples , 2020 .

[20]  J. Malmström,et al.  Interaction with the host: the role of fibronectin and extracellular matrix proteins in the adhesion of Gram-negative bacteria , 2019, Medical Microbiology and Immunology.

[21]  Q. Zou,et al.  DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection , 2019, Molecular Biology Reports.

[22]  R. Shapouri,et al.  Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients , 2019, BMC Infectious Diseases.

[23]  A. Peleg,et al.  The Mechanisms of Disease Caused by Acinetobacter baumannii , 2019, Front. Microbiol..

[24]  V. Müller,et al.  Coping with low water activities and osmotic stress in Acinetobacter baumannii: significance, current status and perspectives. , 2019, Environmental microbiology.

[25]  G. Asokan,et al.  WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain , 2019, Oman medical journal.

[26]  Vandana Solanki,et al.  Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa , 2019, Scientific Reports.

[27]  I. Biswas,et al.  In Vitro Motility Assays for Acinetobacter Species. , 2019, Methods in molecular biology.

[28]  Maricarmen Íñiguez-Moreno,et al.  Biofilm Formation by Staphylococcus aureus Isolated from Food Contact Surfaces in the Dairy Industry of Jalisco, Mexico , 2018, Journal of Food Quality.

[29]  M. Paulsson,et al.  How bacteria hack the matrix and dodge the bullets of immunity , 2018, European Respiratory Review.

[30]  Vishvanath Tiwari,et al.  Targeting Outer Membrane Protein Component AdeC for the Discovery of Efflux Pump Inhibitor against AdeABC Efflux Pump of Multidrug Resistant Acinetobacter baumannii , 2018, Cell Biochemistry and Biophysics.

[31]  Vandana Solanki,et al.  Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii , 2018, Scientific Reports.

[32]  D. Alsteens,et al.  Mechanical Forces Guiding Staphylococcus aureus Cellular Invasion. , 2018, ACS nano.

[33]  F. Yuan,et al.  Binding of Fibronectin to SsPepO Facilitates the Development of Streptococcus suis Meningitis , 2018, The Journal of infectious diseases.

[34]  Vishvanath Tiwari,et al.  Rationale and design of an inhibitor of RecA protein as an inhibitor of Acinetobacter baumannii , 2018, The Journal of Antibiotics.

[35]  Vishvanath Tiwari,et al.  In-silico screening and experimental validation reveal L-Adrenaline as anti-biofilm molecule against biofilm-associated protein (Bap) producing Acinetobacter baumannii. , 2018, International journal of biological macromolecules.

[36]  M. Feldman,et al.  Uncovering the mechanisms of Acinetobacter baumannii virulence , 2017, Nature Reviews Microbiology.

[37]  G. Donelli,et al.  Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action , 2017, Virulence.

[38]  Vandana Solanki,et al.  Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell , 2017, Front. Immunol..

[39]  R. Berisio,et al.  The Burkholderia cenocepacia peptidoglycan‐associated lipoprotein is involved in epithelial cell attachment and elicitation of inflammation , 2017, Cellular microbiology.

[40]  Chien-Cheng Chen,et al.  The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection , 2017, BMC Microbiology.

[41]  Jung Hun Lee,et al.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options , 2017, Front. Cell. Infect. Microbiol..

[42]  P. Rather,et al.  An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075 , 2016, Journal of bacteriology.

[43]  R. Bonomo,et al.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges , 2016, Clinical Microbiology Reviews.

[44]  Syma Khalid,et al.  OmpA: A Flexible Clamp for Bacterial Cell Wall Attachment. , 2016, Structure.

[45]  Alexandre M. J. J. Bonvin,et al.  PRODIGY: a web server for predicting the binding affinity of protein-protein complexes , 2016, Bioinform..

[46]  H. H. Low,et al.  Membrane remodelling in bacteria. , 2016, Journal of structural biology.

[47]  T. Foster,et al.  The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus , 2016, European Journal of Clinical Microbiology and Infectious Diseases.

[48]  L. Visai,et al.  Allosteric Regulation of Fibronectin/α5β1 Interaction by Fibronectin-Binding MSCRAMMs , 2016, PloS one.

[49]  H. Yin,et al.  Drugging Membrane Protein Interactions. , 2016, Annual review of biomedical engineering.

[50]  Vishvanath Tiwari,et al.  Screening of Herbal-Based Bioactive Extract Against Carbapenem-Resistant Strain of Acinetobacter baumannii. , 2016, Microbial drug resistance.

[51]  I. Biswas,et al.  Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates , 2016, Front. Public Health.

[52]  Brian T. Tsuji,et al.  Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance , 2016, Antimicrobial Agents and Chemotherapy.

[53]  Yusen Liu,et al.  KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst. , 2016, Life sciences.

[54]  J. Valle,et al.  Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells , 2016, Virulence.

[55]  Weiwei Huang,et al.  Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii , 2016, Scientific Reports.

[56]  A. M. González-Villoria,et al.  Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen , 2016, Journal of pathogens.

[57]  Medhat A. Haroun,et al.  Development of immunization trials against Acinetobacter baumannii , 2016 .

[58]  I. Rasooli,et al.  Immunogenicity of conserved cork and β-barrel domains of baumannii acinetobactin utilization protein in an animal model. , 2015, Turkish journal of medical sciences.

[59]  Devin K Schweppe,et al.  Host-Microbe Protein Interactions during Bacterial Infection. , 2015, Chemistry & biology.

[60]  Weiwei Huang,et al.  OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections. , 2015, Vaccine.

[61]  H. Hayden,et al.  Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii , 2015, Journal of bacteriology.

[62]  Ming-Hsien Chiang,et al.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology , 2015, Human vaccines & immunotherapeutics.

[63]  M. McConnell,et al.  Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection , 2014, PloS one.

[64]  A. Hartke,et al.  Identification of Peptidoglycan-Associated Proteins as Vaccine Candidates for Enterococcal Infections , 2014, PloS one.

[65]  Bin Chen,et al.  Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models , 2014, PloS one.

[66]  Vishvanath Tiwari,et al.  Conformational stability of OXA-51 β-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii , 2014, Journal of biomolecular structure & dynamics.

[67]  A. Gamian,et al.  Enolase-like protein present on the outer membrane of Pseudomonas aeruginosa binds plasminogen , 2014, Folia Microbiologica.

[68]  J. Pachón,et al.  Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. , 2013, The Journal of infectious diseases.

[69]  K. Seidl,et al.  The MTT assay is a rapid and reliable quantitative method to assess Staphylococcus aureus induced endothelial cell damage. , 2013, Journal of microbiological methods.

[70]  Rui Zhou,et al.  A novel fibronectin-binding protein of Streptococcus suis serotype 2 contributes to epithelial cell invasion and in vivo dissemination. , 2013, Veterinary microbiology.

[71]  Nicole R. Luke-Marshall,et al.  The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization , 2013, Infection and Immunity.

[72]  E. Marcotte,et al.  Role of Pseudomonas aeruginosa Peptidoglycan-Associated Outer Membrane Proteins in Vesicle Formation , 2012, Journal of bacteriology.

[73]  J. Boyce,et al.  Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37 , 2012, Infection and Immunity.

[74]  L. Burrows Pseudomonas aeruginosa twitching motility: type IV pili in action. , 2012, Annual review of microbiology.

[75]  A. Kapil,et al.  Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. , 2012, Microbial pathogenesis.

[76]  A. Kapil,et al.  Comparative Proteomics of Inner Membrane Fraction from Carbapenem-Resistant Acinetobacter baumannii with a Reference Strain , 2012, PloS one.

[77]  R. López-Rojas,et al.  Platelet-activating Factor Receptor Initiates Contact of Acinetobacter baumannii Expressing Phosphorylcholine with Host Cells , 2012, The Journal of Biological Chemistry.

[78]  G. Pier,et al.  Identification of Ata, a Multifunctional Trimeric Autotransporter of Acinetobacter baumannii , 2012, Journal of bacteriology.

[79]  W. Haskins,et al.  Association of Acinetobacter baumannii EF-Tu with Cell Surface, Outer Membrane Vesicles, and Fibronectin , 2012, TheScientificWorldJournal.

[80]  M. McConnell,et al.  Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells , 2012, PloS one.

[81]  M. Adams,et al.  Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection , 2012, PloS one.

[82]  J. Boyce,et al.  Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine , 2011, Antimicrobial Agents and Chemotherapy.

[83]  T. Arimoto,et al.  Surface Lipoprotein PpiA of Streptococcus mutans Suppresses Scavenger Receptor MARCO-Dependent Phagocytosis by Macrophages , 2011, Infection and Immunity.

[84]  R. Coral-Vázquez,et al.  Innate response of human endothelial cells infected with mycobacteria. , 2011, Immunobiology.

[85]  T. Foster,et al.  Fibrinogen Is a Ligand for the Staphylococcus aureus Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) Bone Sialoprotein-binding Protein (Bbp) , 2011, The Journal of Biological Chemistry.

[86]  Y. Mizunoe,et al.  Role of Fibronectin-Binding Proteins A and B in In Vitro Cellular Infections and In Vivo Septic Infections by Staphylococcus aureus , 2011, Infection and Immunity.

[87]  M. McConnell,et al.  Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. , 2010, Vaccine.

[88]  Ruth Nussinov,et al.  An integrated suite of fast docking algorithms , 2010, Proteins.

[89]  R. López-Rojas,et al.  Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii , 2010, Infection and Immunity.

[90]  Yongqun He,et al.  Vaxign: The First Web-Based Vaccine Design Program for Reverse Vaccinology and Applications for Vaccine Development , 2010, Journal of biomedicine & biotechnology.

[91]  Martin Ester,et al.  PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes , 2010, Bioinform..

[92]  Massimo Bernaschi,et al.  Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System , 2010, PloS one.

[93]  J. Johansson,et al.  The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation. , 2010, Biochemical and biophysical research communications.

[94]  M. Kempf,et al.  The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. , 2010, The Journal of infection.

[95]  Chul Hee Choi,et al.  Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. , 2009, FEMS microbiology letters.

[96]  E. K. Jagusztyn-Krynicka,et al.  Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis. , 2009, FEMS microbiology letters.

[97]  T. Weisbrod,et al.  Protection of Mycobacterium tuberculosis from Reactive Oxygen Species Conferred by the mel2 Locus Impacts Persistence and Dissemination , 2009, Infection and Immunity.

[98]  J. Gaddy,et al.  Regulation of Acinetobacter baumannii biofilm formation. , 2009, Future microbiology.

[99]  Chul Hee Choi,et al.  Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells , 2008, BMC Microbiology.

[100]  Hyuk Chu,et al.  Fibronectin facilitates the invasion of Orientia tsutsugamushi into host cells through interaction with a 56-kDa type-specific antigen. , 2008, The Journal of infectious diseases.

[101]  Chul Hee Choi,et al.  Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity , 2007, Cellular microbiology.

[102]  Nichollas E. Scott,et al.  Identification of membrane‐associated proteins from Campylobacter jejuni strains using complementary proteomics technologies , 2008, Proteomics.

[103]  Weiyuan John Kao,et al.  The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function. , 2007, Biomaterials.

[104]  T. Murphy,et al.  Construction of a Mutant and Characterization of the Role of the Vaccine Antigen P6 in Outer Membrane Integrity of Nontypeable Haemophilus influenzae , 2006, Infection and Immunity.

[105]  Jenn-Kang Hwang,et al.  Prediction of protein subcellular localization , 2006, Proteins.

[106]  Christof R Hauck,et al.  Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. , 2006, Current opinion in microbiology.

[107]  S. Hartson,et al.  Adherence of Pasteurella multocida to fibronectin. , 2005, Veterinary microbiology.

[108]  Ruth Nussinov,et al.  PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..

[109]  Jun Yu,et al.  VFDB: a reference database for bacterial virulence factors , 2004, Nucleic Acids Res..

[110]  D. Wiley,et al.  Structure of the human class I histocompatibility antigen, HLA-A2. , 2005, Journal of immunology.

[111]  J. Potts,et al.  The molecular basis of fibronectin‐mediated bacterial adherence to host cells , 2004, Molecular microbiology.

[112]  G. Wyatt,et al.  A comparison of the traditional method of counting viable cells and a quick microplate method for monitoring the growth characteristics of Listeria monocytogenes , 2004, Letters in applied microbiology.

[113]  A. Yamaguchi,et al.  Membrane topology of ABC‐type macrolide antibiotic exporter MacB in Escherichia coli , 2003, FEBS letters.

[114]  K. Kim,et al.  Fibronectin mediates Opc‐dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells , 2002, Molecular microbiology.

[115]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Identification of virulence factors of Streptococcus suis , 2011 .

[116]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[117]  S. Johansson,et al.  Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. , 2000, European journal of cell biology.

[118]  J. Chia,et al.  Identification of a Fibronectin Binding Protein from Streptococcus mutans , 2000, Infection and Immunity.

[119]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.

[120]  A. Koide,et al.  The fibronectin type III domain as a scaffold for novel binding proteins. , 1998, Journal of molecular biology.

[121]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.